Early investigational drugs that target epidermal growth factor receptors for the treatment of head and neck cancer

Sadeleştirilmiş öğe sayfası
dc.contributor.authorUgurluer, Gamze
dc.contributor.authorOzsahin, Mahmut
dc.date.accessioned2025-10-16T15:32:11Z
dc.date.issued2014
dc.identifier.doi10.1517/13543784.2014.951435
dc.identifier.otherWOS:000344699900004
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/9108
dc.publisherTAYLOR \& FRANCIS LTD
dc.sourceEXPERT OPINION ON INVESTIGATIONAL DRUGS
dc.subjectchemoprevention
dc.subjectEGFR
dc.subjecthead and neck cancer
dc.subjectmonoclonal antibodies
dc.subjecttyrosine kinase inhibitors
dc.titleEarly investigational drugs that target epidermal growth factor receptors for the treatment of head and neck cancer
dc.typeReview

Dosyalar

Koleksiyonlar

WOS